We next tested induced pluripotent stem (iPS) cell lines derived from PD patients with PINK1 mutations (i.e. c.1366C>T; p.Q456X nonsense mutations; L2124) to assess the potential effect of USP14 inhibition. This evidence concerns the gene USP14 and Parkinson disease.